We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Self-Administered HPV Test Helps Screen for Cervical Cancer

By LabMedica International staff writers
Posted on 09 Feb 2012
Patient-collected specimens for human papillomavirus (HPV) DNA testing detected precancerous cervical lesions with an accuracy comparable to that of liquid-based cytology (LBC) and visual inspection with acetic acid, according to a new study.

Researchers at Peking Union Medical College (PUMC; Beijing, China), Mount Sinai School of Medicine (New York, NY, USA), and other institutions worldwide reviewed patient data from five population-based cervical cancer–screening studies in China. More...
In all, 13,140 participants underwent Self-HPV testing, physician-collected cervical specimens for HPV testing, LBC, and visual inspection with acetic acid (VIA). Screen-positive women had a subsequent colposcopy and confirmatory biopsy. The researchers than analyzed the accuracies of pooled Self-HPV testing, Physician-HPV testing, VIA, and LBC to detect biopsy-confirmed cervical intraepithelial neoplasia grade 2 or more severe (CIN2+), and CIN3+.

The results showed that 3.9% of the women were diagnosed as CIN2+, 2.1% as CIN3+, and 0.3% with cervical cancer. Self-HPV testing had 86.2% sensitivity and 80.7% specificity for detecting CIN2+, and 86.1% sensitivity and 79.5% specificity for detecting CIN3+. VIA had statistically significantly lower sensitivity for detecting CIN2+ and CIN3+, and higher specificity for detecting CIN2+ and CIN3+ than Self-HPV testing, while LBC had lower sensitivity for detecting CIN2+, similar sensitivity for detecting CIN3+, and higher specificity for detecting CIN2+ and CIN3+ than Self-HPV testing. Physician-HPV testing, on the other hand, was more sensitive for detecting CIN2+ and CIN3+, but similarly specific for detecting CIN2+ and CIN3+ than Self-HPV testing.

“Although it is not specific enough to be a stand-alone test, self-HPV testing provides sensitive results without pelvic exams, medical professionals, or healthcare facilities and thus has the potential to serve as a primary cervical cancer screening method for women, regardless of their geographic location or access to healthcare,” concluded lead author You-Lin Qiao, MD, PhD, of PUMC. “Limited resources can then be focused on the clinical follow up of the smaller percentage of women who tested positive.”

One-seventh of all cervical cancers worldwide occur in China, which lacks a national screening program. Self-collected cervicovaginal specimens tested for HPV DNA could therefore effectively serve as a primary cervical cancer screening method in China and other low-resource settings.

Related Links:
Peking Union Medical College
Mount Sinai School of Medicine


Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Urine Analyzer
respons® UDS100
New
Repetitive Pipette
VWR® Stepper Pro
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers identified eight new DNA pattern signatures that could help refine diagnostics and guide targeted therapy in breast cancer (image credit: 123RF)

Breast Cancer-Specific Signatures Link Genome Instability to Outcomes

Genomic instability is a hallmark of cancer, but most genomic analyses have relied on broad signatures shared across multiple malignancies, limiting their precision for individual tumor types.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.